Annual report pursuant to Section 13 and 15(d)

Loss Per Share (Tables)

v3.23.2
Loss Per Share (Tables)
12 Months Ended
Jun. 30, 2023
Loss Per Share [Abstract]  
Schedule of Common Stock Equivalents The Company had the following common stock equivalents at June 30, 2023 and 2022:
    June 30,
2023
    June 30,
2022
 
Convertible Notes     9,341,825       9,341,825  
Options     3,156,037       3,020,002  
Warrants    
      41,103  
Total     12,497,862       2,664,686